COMMUNIQUÉS West-GlobeNewswire

Sanofi Head of Global R&D Elias Zerhouni to retire; Company names John Reed to take over on July 1
24/04/2018
Press Release Source: Sanofi (EURONEXT: SAN) (NYSE: SNY) Sanofi Head of Global R&D Elias Zerhouni to retire; Company names John Reed to take over on July 1 Paris - 24 th April 2018 -- Elias Zerhouni, M.D., Head of [...]
Départ à la retraite du Président Monde de la R&D de Sanofi, Elias Zerhouni ; L'entreprise nomme John Reed pour lui succéder à compter du 1er juillet
24/04/2018
Communiqué de presse Source : Sanofi (EURONEXT : SAN) (NYSE : SNY) Départ à la retraite du Président Monde de la R&D de Sanofi, Elias Zerhouni ; L'entreprise nomme John Reed pour lui succéder à compter du 1 er [...]
PUBLICATION IN ACCORDANCE WITH ARTICLE 14 OF THE BELGIAN LAW OF 2 MAY 2007 REGARDING THE PUBLICATION OF MAJOR SHAREHOLDINGS (THE "TRANSPARENCY LAW")
24/04/2018
REGULATED INFORMATION GHENT, Belgium, 24 April 2018 - Ablynx [Euronext Brussels and Nasdaq: ABLX] today announced, in accordance with Article 14 of the Belgian Law of 2 May 2007 regarding the publication of major [...]
Targovax ASA: Invitation to first quarter 2018 results presentation Thursday 3 May
24/04/2018
Oslo, Norway, 24 April 2018 - Targovax ASA (OSE: TRVX), a clinical stage company focused on developing immuno-oncology therapies to target solid tumors, will announce its first quarter 2018 results on Thursday, 3 May [...]
MDxHealth Provides First Quarter 2018
24/04/2018
NEWS RELEASE REGULATED INFORMATION INTERIM TRADING UPDATE MDxHealth Provides First Quarter 2018 Business Update IRVINE, CA, and HERSTAL, BELGIUM - 07:00 CEST, April 24, 2018 - MDxHealth SA ("MDxHealth, or the "Company [...]
MDxHealth publie ses résultats du premier trimestre 2018
24/04/2018
COMMUNIQUÉ DE PRESSE INFORMATIONS REGLEMENTÉES RAPPORT D'ACTIVITÉS TEMPORAIRE MDxHealth publie ses résultats du premier trimestre 2018 IRVINE, CA, et HERSTAL, BELGIQUE - 07h00 CEST, mardi 24 avril 2018 - MDxHealth SA [...]
argenx to present complete data from the Phase 2 proof-of-concept trial of efgartigimod (ARGX-113) in generalized myasthenia gravis at American Academy of Neurology (AAN) Annual Meeting
24/04/2018
Eight-week follow-up data show separation of clinical efficacy scores between treatment group and placebo group through the duration of study Total and pathogenic IgG reduction correlates with disease score improvements [...]
Axiom Real-Time Metrics Exhibiting Fusion eClinical Suite at Clinical Operations in Oncology Trials West
24/04/2018
TORONTO, April 23, 2018 (GLOBE NEWSWIRE) -- Axiom Real-Time Metrics, premier provider of unified eClinical solutions and services, is exhibiting at Clinical Operations in Oncology Trials West on April 24 th and 25 th in [...]
Immuron CEO to Present at RedChip Global Online Growth Conference
24/04/2018
MELBOURNE, Australia, April 23, 2018 (GLOBE NEWSWIRE) -- Immuron Limited (ASX:IMC) (NASDAQ: IMRN ), Australian microbiome biopharmaceutical company focused on developing and commercialising orally delivered targeted [...]
Apellis Pharmaceuticals Announces Closing of Offering of Common Stock
24/04/2018
CRESTWOOD, Ky. and WALTHAM, Mass., April 23, 2018 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals, Inc. (Nasdaq: APLS ), a clinical-stage biopharmaceutical company focused on the development of novel therapeutic compounds [...]
Epizyme Provides Update Regarding Tazemetostat Clinical Program
23/04/2018
CAMBRIDGE, Mass., April 23, 2018 (GLOBE NEWSWIRE) -- Epizyme, Inc. (NASDAQ: EPZM ), a clinical-stage company developing novel epigenetic therapies, today announced that U.S.-based enrollment of new patients into [...]
Surface Oncology Announces Closing of $119.5 Million Aggregate Financing, Consisting of $108.0 Million Initial Public Offering and $11.5 Million Concurrent Private Placement
23/04/2018
CAMBRIDGE, Mass., April 23, 2018 (GLOBE NEWSWIRE) -- Surface Oncology, Inc. (“Surface”), an immuno-oncology company developing next-generation antibody therapies that target the tumor microenvironment, today announced [...]
Brian Andrews to Succeed Albert White as Chief Financial Officer of The Cooper Companies
23/04/2018
PLEASANTON, Calif., April 23, 2018 (GLOBE NEWSWIRE) -- The Cooper Companies, Inc. (NYSE: COO ) today announced that Brian Andrews has been promoted to Senior Vice President, Chief Financial Officer and Treasurer of The [...]
Natus Confirms Receipt of Notice of Voce Capital’s Intent to Nominate Director Candidates to Replace 50% of the Natus Board
23/04/2018
No Shareholder Action Required at this Time PLEASANTON, Calif., April 23, 2018 (GLOBE NEWSWIRE) -- Natus Medical Incorporated (NASDAQ: BABY ) (“Natus” or the “Company”) today confirmed that Voce Capital Management LLC [...]
Genesis HealthCare Sells 51% Stake in Chinese Subsidiary GRS-HS to Riswein Health Industry Investment Co., Ltd
23/04/2018
KENNETT SQUARE, Pa., April 23, 2018 (GLOBE NEWSWIRE) -- Genesis HealthCare (Genesis, or the Company) (NYSE: GEN ), one of the largest post-acute care providers in the United States, today announced that it has signed a [...]
Harvard Bioscience Schedules First Quarter 2018 Conference Call for May 2 at 4:30 PM ET
23/04/2018
HOLLISTON, Mass., April 23, 2018 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO ), a global developer, manufacturer and marketer of a broad range of solutions to advance life science, will announce results [...]
ChromaDex Appoints Frank Jaksch As Executive Chairman, Rob Fried as Chief Executive Officer and Kurt Gustafson as Lead Director
23/04/2018
New Management Structure Further Fuels Strategic Evolution into Consumer-Focused Integrated Nutraceutical Company IRVINE, Calif., April 23, 2018 (GLOBE NEWSWIRE) -- ChromaDex Corp. (NASDAQ: CDXC ), an integrated, [...]
Tivity Health Reports First-Quarter 2018 Results and Affirms Financial Guidance
23/04/2018
REVENUES OF $150 MILLION AND DILUTED EPS OF $0.49 ANNOUNCES HIRING OF CHIEF BRAND OFFICER NASHVILLE, Tenn., April 23, 2018 (GLOBE NEWSWIRE) -- Tivity Health, Inc. (NASDAQ: TVTY ) today announced financial results for [...]
Avadim Technologies Receives Notices of Allowance From U.S. and Japan Patent Offices for Inventions Related to Reducing Catheter Associated Urinary Tract Infections (CAUTI)
23/04/2018
ASHEVILLE, N.C., April 23, 2018 (GLOBE NEWSWIRE) -- Avadim Technologies, Inc. (“Avadim”), the Bionome Therapies TM life sciences company, announced today that its patent applications have been allowed in the U.S. and [...]

Pages